Literature DB >> 9562278

Systemic cytokine response to hepatic resections under total vascular exclusion.

J M Badia1, L C Ayton, T J Evans, A J Carpenter, G Nawfal, H Kinderman, G Zografos, S Uemoto, J Cohen, N A Habib.   

Abstract

OBJECTIVE: To investigate the systemic cytokine response to major liver surgery as the basis for assessing potential new treatments.
DESIGN: Open prospective study.
SETTING: University hospital, UK.
SUBJECTS: Thirteen patients undergoing elective hepatic resections that involved total vascular exclusion of the liver.
INTERVENTIONS: Blood samples were taken preoperatively, during the operation, and during the first four postoperative days. Concentrations of endotoxin, interferon gamma (IFN-gamma), tumour necrosis factor alpha (TNFalpha), interleukin-1 (IL-1), and interleukin-6 (IL-6) were measured.
RESULTS: Endotoxin concentrations were raised in 3/13 patients before operation and in 6 patients during the postoperative period. TNFalpha concentrations were undetectable. IFN-gamma and IL-1 responses followed a low and inconclusive pattern. IL-6 was significantly increased from 6 hours after operation to the third postoperative day, peaking at 699 (+/-277) pg/ml at 24 hours (p < 0.01). The two patients who died had the highest postoperative concentrations of IL-6.
CONCLUSIONS: There is a pronounced systemic response to hepatic resection under total vascular exclusion that is reflected by the increase in IL-6 concentration and correlates with the operative blood loss and postoperative outcome. This might be used as an indicator of the response to specific treatments in this type of surgery. Treatments that minimise the IL-6 response to major hepatic resection may be of value.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562278     DOI: 10.1080/110241598750004625

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  9 in total

1.  Gut and liver handling of interleukin-6 during liver resection in man.

Authors:  Simon A W G Dello; Johanne G Bloemen; Marcel C G van de Poll; Ronald M van Dam; Jan H M B Stoot; Maartje A J van den Broek; Wim A Buurman; Marc H A Bemelmans; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  HPB (Oxford)       Date:  2011-03-07       Impact factor: 3.647

2.  Effect of portal vein occlusion on the pancreas: an experimental model.

Authors:  Hasan Aydede; Yamac Erhan; Ozer Ikgül; Serap Cilaker; Aslan Sakarya; Seda Vatansever
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

Review 3.  Novel therapy for liver regeneration by increasing the number of platelets.

Authors:  Kazuhiro Takahashi; Soichiro Murata; Nobuhiro Ohkohchi
Journal:  Surg Today       Date:  2012-11-21       Impact factor: 2.549

4.  Early post-operative measurement of cytokine plasma levels combined with pre-operative bilirubin levels identify high-risk patients after liver resection.

Authors:  Christoph W Strey; Rosa Maria Marquez-Pinilla; Maciej M Markiewski; Britta Siegmund; Elsie Oppermann; John D Lambris; Wolf O Bechstein
Journal:  Int J Mol Med       Date:  2010-12-28       Impact factor: 4.101

5.  Stress response to laparoscopic liver resection.

Authors:  Kazuki Ueda; Patricia Turner; Michel Gagner
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

Review 6.  Use of pre-operative steroids in liver resection: a systematic review and meta-analysis.

Authors:  Arthur J Richardson; Jerome M Laurence; Vincent W T Lam
Journal:  HPB (Oxford)       Date:  2013-03-06       Impact factor: 3.647

Review 7.  Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma.

Authors:  Ioannis A Ziogas; Georgios Tsoulfas
Journal:  World J Gastrointest Surg       Date:  2017-12-27

Review 8.  Computational Modeling in Liver Surgery.

Authors:  Bruno Christ; Uta Dahmen; Karl-Heinz Herrmann; Matthias König; Jürgen R Reichenbach; Tim Ricken; Jana Schleicher; Lars Ole Schwen; Sebastian Vlaic; Navina Waschinsky
Journal:  Front Physiol       Date:  2017-11-14       Impact factor: 4.566

Review 9.  Platelets in liver disease, cancer and regeneration.

Authors:  Tomohiro Kurokawa; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.